Ccc_R08
Ccc_R08 is an orally available HBV cccDNA inhibitor that reduces extracellular levels of HBV DNA, HBsAg, and HBeAg in a dose-dependent manner. ccc_R08 is investigational for use in the treatment of HBV infections. ccc_R08 has been shown to be effective in the treatment of hepatitis C virus (HCV) .
Product Specifications
CAS Number
2919019-72-8
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
414.84
Molecular Formula
C22H19ClO6
Notes
Research use only, not for human use.
Receptor
HBV
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog